HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists.

作者: Gordon W. Dewald , Linda D. Cooley , James T. Mascarello , Patricia K. Dowling , Daynna J. Wolff

DOI: 10.1043/1543-2165(2006)130[325:HFISHR]2.0.CO;2

关键词: Medical physicsProficiency testingFluorescence in situ hybridizationCytogeneticsCommon methodGynecologyBreast cancerMedicineFish <Actinopterygii>

摘要: Abstract Context.—Fluorescence in situ hybridization (FISH) is a common method used to determine HER-2 status breast cancer. Limited information available concerning reproducibility of FISH determining gene amplification. Objective.—To present proficiency testing results for conducted by the Cytogenetics Resource Committee College American Pathologists/American Medical Genetics. Design.—During past 5 years, unstained sections from 9 invasive carcinomas were testing, allowing comparison among large number laboratories. Additional data collected using an educational (ungraded) challenge and supplemental questions surveys. Results.—The laboratories participating has increased steadily during years (from 35 2000 139 2004). Reproducibility test was excellent tumors with low copy ...

参考文章(48)
Laura Casorzo, Stefania Redana, Filippo Montemurro, Mauro Risio, HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment Oncology Reports. ,vol. 13, pp. 305- 309 ,(2005) , 10.3892/OR.13.2.305
B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049
Michael F. Press, Dennis J. Slamon, Kerry J. Flom, Jinha Park, Jian-Yuan Zhou, Leslie Bernstein, Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Journal of Clinical Oncology. ,vol. 20, pp. 3095- 3105 ,(2002) , 10.1200/JCO.2002.09.094
M F Press, L Bernstein, P A Thomas, L F Meisner, J Y Zhou, Y Ma, G Hung, R A Robinson, C Harris, A El-Naggar, D J Slamon, R N Phillips, J S Ross, S R Wolman, K J Flom, HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Journal of Clinical Oncology. ,vol. 15, pp. 2894- 2904 ,(1997) , 10.1200/JCO.1997.15.8.2894
R.R. Tubbs, J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, T.M. Grogan, Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message Journal of Clinical Oncology. ,vol. 19, pp. 2714- 2721 ,(2001) , 10.1200/JCO.2001.19.10.2714
S Toikkanen, H Helin, J Isola, H Joensuu, Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. Journal of Clinical Oncology. ,vol. 10, pp. 1044- 1048 ,(1992) , 10.1200/JCO.1992.10.7.1044
Joan Albanell, Larry Norton, Jose Baselga, Young Mee Kim, John Mendelsohn, Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts Cancer Research. ,vol. 58, pp. 2825- 2831 ,(1998)
Ann D. Thor, Donald A. Berry, Daniel R. Budman, Hyman B. Muss, Timothy Kute, I. Craig Henderson, Maurice Barcos, Constance Cirrincione, Susan Edgerton, Craig Allred, Larry Norton, Edison T. Liu, erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer Journal of the National Cancer Institute. ,vol. 90, pp. 1346- 1360 ,(1998) , 10.1093/JNCI/90.18.1346
Shikha Bose, Mansoor Mohammed, Peter Shintaku, P Nagesh Rao, None, Her-2/neu Gene Amplification in Low to Moderately Expressing Breast Cancers: Possible Role of Chromosome 17/Her-2/neu Polysomy The Breast Journal. ,vol. 7, pp. 337- 344 ,(2001) , 10.1046/J.1524-4741.2001.21018.X